Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

interferon alfacon-1

An analogue of consensus interferon which contains an additional methionyl amino acid residue. Consensus interferon (also known as interferon alfacon-1, rCon-IFN, and CIFN) is a genetically engineered synthetic interferon created from the most common amino acid sequences from the naturally occurring alpha interferons. Alpha interferons bind to specific cell-surface receptors, resulting in the transcription and translation of genes whose protein products have antiviral, antiproliferative, anticancer, and immune-modulating effects.
Synonym:consensus interferon
IFN alfacon-1
interferon consensus, methionyl
methionyl interferon consensus
methionyl-interferon-consensus
recombinant consensus interferon
recombinant methionyl human consensus interferon
US brand name:Infergen
Foreign brand name:Advaferon
Abbreviation:CIFN
r-metHuIFN-Con1
Search NCI's Drug Dictionary